Scinai Immunotherapeutics jumps on $2.61M private placement financing

By: Quiver PriceTracker

Posted: 5 hours ago / April 24, 2026 9:21 p.m. UTC

SCNI

Scinai Immunotherapeutics Ltd. (SCNI) is up 57.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to Scinai’s announcement of a $2.61 million private placement paired with a warrant inducement, which can be a meaningful liquidity catalyst for a micro-cap stock. Traders may also be reacting to the pricing and warrant structure, as well as the expected near-term closing timeline.

Details:

The company entered into a securities purchase agreement for 5,208,333 ADSs priced at $0.48 per ADS, along with two series of immediately exercisable warrants.

The financing also included a warrant inducement tied to the cash exercise of existing warrants for up to 229,310 ADSs, with new unregistered warrants issued as consideration.

Gross proceeds for the combined transactions were announced at approximately $2.61 million (before fees and expenses), with closing expected on or about April 27, 2026, subject to customary conditions.

Management stated the net proceeds, along with existing cash, are intended to support expansion of its CDMO platform, advance customer programs, and continue selective investment in its immunotherapy pipeline.

Sources:

Scinai (press release), Investing.com, StockTitan

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$SCNI Hedge Fund Activity

We have seen 5 institutional investors add shares of $SCNI stock to their portfolio, and 3 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

XTX TOPCO LTD added 27,294 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,436
VIRTU FINANCIAL LLC added 15,409 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,972
TWO SIGMA SECURITIES, LLC removed 14,696 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,465
CITADEL ADVISORS LLC added 5,932 shares (+20.7%) to their portfolio in Q4 2025, for an estimated $4,224
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 2,000 shares (+200.0%) to their portfolio in Q4 2025, for an estimated $1,424
UBS GROUP AG added 1,740 shares (+21750.0%) to their portfolio in Q4 2025, for an estimated $1,239
RHUMBLINE ADVISERS removed 1,675 shares (-47.1%) from their portfolio in Q4 2025, for an estimated $1,192

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.